UCSF

ZINC03914808

Substance Information

In ZINC since Heavy atoms Benign functionality
October 18th, 2005 28 No

Other Names:

(+)-chenodeoxycholate; (+)-chenodeoxycholic acid; (3a,5b,7a)-3,7-dihydroxy-cholan-24-oate; (3a,5b,7a)-3,7-dihydroxy-cholan-24-oic acid; 3a,7a-Dihydroxy-5b,14a,17b-cholanate; 3a,7a-Dihydroxy-5b,14a,17b-cholanic acid; 3a,7a-Dihydroxy-5b-cholan-24-oate; 3a,7

(+)-chenodeoxycholate;(+)-chenodeoxycholic acid;(3a,5b,7a)-3,7-dihydroxy-cholan-24-oate;(3a,5b,7a)-3,7-dihydroxy-cholan-24-oic acid;3a,7a-Dihydroxy-5b,14a,17b-cholanate;3a,7a-Dihydroxy-5b,14a,17b-cholanic acid;3a,7a-Dihydroxy-5b-cholan-24-oate;3a,7a-Dihyd

(3a,7a)-3,7-dihydroxy-Cholan-24-oate;(3a,7a)-3,7-dihydroxy-Cholan-24-oic acid;3a,7a-Dihydroxy-cholanoate;3a,7a-Dihydroxy-cholanoic acid;3a,7a-Dihydroxycholanoate;3a,7a-Dihydroxycholanoic acid

(3alpha,5beta,7alpha,8xi)-3,7-dihydroxycholan-24-oic acid; (3beta,7beta,8xi,9xi,14xi,17alpha)-3,7-dihydroxycholan-24-oic acid; 3-alpha,7-alpha-Dihydroxy-5-beta-cholan-24-oic acid; 3-alpha,7-alpha-Dihydroxycholanic acid; 3-alpha,7-alpha-Dihydroxycholansaeu

(4R)-4-[(1S,2S,5R,7S,9R,11S,14R,15R)-5,9-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoic acid

(4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid

3a,7a-Dihydroxycholanoic acid

3alpha, 7alpha-Dihydroxy-5beta-cholanic acid

3alpha, 7alpha-dihydroxy-5beta-cholanic acid; 474-25-9; chenodeoxycholate; chenodexycholic acid

3alpha,7alpha-Dihydroxy-5beta-cholan-24-oic Acid

3alpha,7alpha-Dihydroxy-5beta-cholanic acid; 474-25-9; C02528; Chenodeoxycholate; Chenodeoxycholic acid; Chenodiol

474-25-9; Chenix (TN); Chenodeoxycholic acid (JP16/INN); Chenodiol (USAN); D00163

474-25-9; Chenodiol; Prestwick_553

634

7alpha-hydroxylithocholic acid; CDCA; Chenix; anthropodeoxycholic acid; anthropodesoxycholic acid; chenic acid; gallodesoxycholic acid

A___PH001407

CDCA

CHEBI:3593; CHEBI:3588; CHEBI:23094

Chenic acid

Chenix

Chenocholic acid

Chenodal

Chenodeoxycholate

Chenodeoxycholic Acid (BAN

CHENODEOXYCHOLIC ACID SODIUM

Chenodeoxycholic acid, 97+%

Chenodeoxycholic acid, 98%

CHENODEOXYCHOLIC ACID; [474-25-9]

Chenodesoxycholic acid

Chenodiol

Chenodiol (FDA

Chenodiol, Chenodesoxycholic acid, Chenocholic acid

Chenofalk

Chenorm

DNC000420

INN

JAN)

JAN); Chenodiol (FDA

MFCD00064142

MFCD18785548

QA-9583

URSODEOXYCHOLIC ACID

USAN)

USAN); Chenodeoxycholic Acid (BAN

Xenbilox

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 4.25 7.71 -48 2 4 -1 81 391.572 4
Lo Low (pH 4.5-6) 4.25 5.73 -8.53 3 4 0 78 392.58 4

Vendor Notes

Note Type Comments Provided By
Molecular_Solubility 5.723 Bitter DB
ALOGPS_SOLUBILITY 1.97e-02 g/l DrugBank-approved
Mp [°C] 162 - 168 Acros Organics
MP 165 - 167 Enamine Building Blocks
M.P 165-167 °C Indofine
MP 165...167 Enamine Building Blocks
purity 9.500000000000000e+001 Enamine Building Blocks Enamine Building Blocks
Purity 95% Fluorochem
UniProt Database Links A85C_MYCTU; AK1C1_HUMAN; AK1C2_HUMAN; AK1D1_HUMAN; CDC14_EMENI; CP7A1_HUMAN; CP7A1_RAT; CP8B1_HUMAN; CP8B1_MOUSE; CP8B1_PIG; CP8B1_RABIT; FABP6_HUMAN; HCD2_HUMAN; NR1H4_BOVIN; NR1H4_HUMAN; NR1H4_MOUSE; NR1H4_RAT; OVUH_LYMST ChEBI
Patent Database Links EP1832575; EP1886685; US2007219172; WO2007086651; WO2007096431; WO2007101606; WO2007106049 ChEBI
H phrase H315: Causes skin irritation; H319: Causes serious eye irritation Acros Organics
H phrase H361d: Suspected of damaging the unborn child Acros Organics
Target NULL Selleck Chemicals
P phrase P281: Use personal protective equipment as required Acros Organics
P phrase P302 + P352: IF ON SKIN: Wash with plenty of soap and water; P305 + P351 + P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing; P280: Wear protective gloves/protective cloth Acros Organics
SOLUBILITY PRACTICALLY INSOLUBLE Indofine
R phrase R36/38: Irritating to eyes and skin. Acros Organics
R phrase R63: Possible risk of harm to the unborn child. Acros Organics
Reactome Database Links REACT_10034; REACT_10050; REACT_10072; REACT_10078; REACT_17008; REACT_21388; REACT_22234; REACT_22268; REACT_9412; REACT_9468; REACT_9502 ChEBI
S phrase S36/37: Wear suitable protective clothing and gloves. Acros Organics
PUBCHEM_PATENT_ID WO1999058549A1 IBM Patent Data
Hazard XI: Irritant Acros Organics
Hazard XN: Harmful Acros Organics

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
NR1H4-2-E Bile Acid Receptor FXR (cluster #2 Of 2), Eukaryotic Eukaryotes 8660 0.25 Binding ≤ 10μM
GPBAR-2-E G-protein Coupled Bile Acid Receptor 1 (cluster #2 Of 2), Eukaryotic Eukaryotes 6710 0.26 Functional ≤ 10μM
NR1H4-2-E Bile Acid Receptor FXR (cluster #2 Of 2), Eukaryotic Eukaryotes 8660 0.25 Functional ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
NR1H4_HUMAN Q96RI1 Bile Acid Receptor FXR, Human 3400 0.27 Binding ≤ 10μM
NR1H4_HUMAN Q96RI1 Bile Acid Receptor FXR, Human 6310 0.26 Functional ≤ 10μM
GPBAR_HUMAN Q8TDU6 G-protein Coupled Bile Acid Receptor 1, Human 6710 0.26 Functional ≤ 10μM

Direct Reactome Annotations (via ChEBI)

Description Species
Class A/1 (Rhodopsin-like receptors)
Digestion of dietary lipid
Endogenous sterols
G alpha (s) signalling events
PPARA activates gene expression
Recycling of bile acids and salts
Synthesis of bile acids and bile salts
Synthesis of bile acids and bile salts via 27-hydroxycholesterol
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol
Transport of organic anions

Reactome Annotations from Targets (via Uniprot)

Description Species
Class A/1 (Rhodopsin-like receptors)
Endogenous sterols
G alpha (s) signalling events
PPARA activates gene expression
Recycling of bile acids and salts
Synthesis of bile acids and bile salts
Synthesis of bile acids and bile salts via 27-hydroxycholesterol
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol

Analogs ( Draw Identity 99% 90% 80% 70% )